Keyword Suggestion
Domain Informations
Aranesp.com lookup results from whois.markmonitor.com server:
- Domain created: 1999-09-13T21:36:04Z
- Domain updated: 2024-08-12T09:09:37Z
- Domain expires: 2025-09-13T21:36:04Z 0 Years, 304 Days left
- Website age: 25 Years, 61 Days
- Registrar Domain ID: 10131304_DOMAIN_COM-VRSN
- Registrar Url: http://www.markmonitor.com
- Registrar WHOIS Server: whois.markmonitor.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2086851750
- Name server:
- NS-1458.AWSDNS-54.ORG
- NS-2012.AWSDNS-59.CO.UK
- NS-34.AWSDNS-04.COM
- NS-565.AWSDNS-06.NET
Network
- inetnum : 52.84.0.0 - 52.95.255.255
- name : AT-88-Z
- handle : NET-52-84-0-0-1
- status : Direct Allocation
- created : 2011-12-08
- changed : 2024-01-24
- desc : All abuse reports MUST include:,* src IP,* dest IP (your IP),* dest port,* Accurate date/timestamp and timezone of activity,* Intensity/frequency (short log extracts),* Your contact details (phone and email) Without these we will be unable to identify the correct owner of the IP address at that point in time.
Owner
- organization : Amazon Technologies Inc.
- handle : AT-88-Z
- address : Array,Seattle,WA,98109,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 52.89.252.97
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 52.89.252.97)
Spam Check (IP: 52.89.252.97)
Recent Searched Sites
› Eropho.net (32 seconds ago) / US
› Halesowennews.co.uk (33 seconds ago) / GB
› Newsshopper.co.uk (5 seconds ago) / GB
› Times-series.co.uk (9 seconds ago) / GB
› Free-cosmetic-testing.com (3 seconds ago) / DE
› Blog.yani.ai (5 seconds ago) / US
› Romfordrecorder.co.uk (1 seconds ago) / GB
› Anarchia.gg (18 seconds ago) / US
› Shropshirelive.com (44 seconds ago) / DE
› Fishingwa.us (2 seconds ago) / US
› Yourhometownmutual.com (13 seconds ago) / US
› Southwalesargus.co.uk (1 mins ago) / GB
› Apkxi.com (21 seconds ago) / US
› Support.epiloglaser.com (26 seconds ago) / US
› Yeildingmd.com (17 seconds ago) / US
› Aranesp.com (0 seconds ago) / US
› Vadentist.com (24 seconds ago) / US
› Voba-mg.de (28 seconds ago) / DE
› Mckinney-stentoft.blogbright.net (7 seconds ago) / DE
› Aircarry.com (6 seconds ago) / JP
Websites Listing
We found Websites Listing below when search with aranesp.com on Search Engine
Aranesp® (darbepoetin alfa) | Dosing Considerations
For anemia patients with non-myeloid malignancies receiving concomitant myelosuppressive chemotherapy Aranesp ® is the only long-acting erythropoiesis-stimulating agent (ESA) approved for both once weekly (QW) and once every three weeks (Q3W) dosing 1,2 Aranesp ® dosing options of QW or Q3W may allow for synchronization with common myelosuppressive …
Aranesp.comAranesp Patient Instructions for Use - Autoinjector
Check that your single-use Aranesp prefilled SureClick™ autoinjector is the correct dose that your healthcare provider has prescribed. 3. Do not use your autoinjector after the expiration date on the carton and on the autoinjector label. 4. Remove the autoinjector from the box. During this time, protect the solution from light. 5. Do not warm your single-use Aranesp prefilled …
Accessdata.fda.govAranesp - Rexall
Aranesp. of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Rexall.caAmgen Canada
Searching for the Answers Within. At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.
Amgen.caPrise en charge anémie – Nephro.blog
Aranesp ® Amgen: seringue à 10, 15, 20, 30, 40, 50, 60, 80, 100, 130, 150, 300 et 500 µg ... Avertissez-moi par e-mail des nouveaux commentaires. Avertissez-moi par e-mail des nouveaux articles. Δ . Ce site utilise Akismet pour réduire les indésirables. En savoir plus sur la façon dont les données de vos commentaires sont traitées. Trouver un article sur Nephroblog. …
Nephro.blogARANESP® (darbepoetin alfa) injection– Gafacom
2021-09-01 · ARANESP® (darbepoetin alfa) injection Darbepoetin alfa is an erythropoiesis-stimulating protein that is produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. Darbepoetin alfa is a 165-amino acid protein that differs from recombinant human erythropoietin in containing 5 N-linked oligosaccharide chains, whereas recombinant human …
Gafacom.websiteAmgen Celebrates 20 Years of Aranesp ® (darbepoetin alfa) as a ...
2001-09-17 · On September 17, 2001, the vision of one Amgen team was realized with the FDA approval of Aranesp ® for treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis and not on dialysis. 2. Steve Elliott, PhD, one of the key scientists involved in the development of Aranesp ®, and a retired member of the Amgen team, shared how his team …
Amgen.comAranesp® Aranesp - GuildLink
Aranesp is recombinant erythropoietic protein produced by special mammalian cells. Aranesp is used to treat anaemia. Anaemia is a condition where the blood does not contain a sufficient amount of red blood cells. The symptoms of anaemia may include fatigue, dizziness, increased heart rate, depression, nausea, loss of appetite, feeling cold, shortness of breath and pale skin …
Guildlink.com.auAranesp - Uses, Side Effects, Interactions - MedBroadcast.com
Aranesp: These medications are used to replace the erythropoietin that is lacking in people whose own bodies cannot produce enough. Erythropoietin is produced naturally in the body, mostly by the kidneys. It gives bone marrow the signal to produce red blood cells, which carry oxygen in the blood. If the body does not produce enough erythropoietin, severe anemia (a …
Medbroadcast.comDarbepoetin Alfa (Injection Route) Description and Brand Names
2022-02-01 · Aranesp; Descriptions. Darbepoetin alfa injection causes the bone marrow to produce red blood cells. If the body does not produce enough red blood cells, severe anemia can occur. This often occurs in people with chronic kidney failure whose kidneys are not working properly. Darbepoetin may be used for patients on kidney dialysis or for those ...
Mayoclinic.orgARANESP PFS - Patient Information Leaflet (PIL) - (emc)
2022-04-04 · Aranesp is a clear, colourless or slightly pearly solution for injection in a pre-filled syringe. Aranesp is available in packs of 1 or 4 pre-filled syringes. The syringes are provided either with (1- and 4-pack) or without (1-pack) a blister-wrapping. Not all …
Medicines.org.ukAranesp Side Effects, User Reviews and Expert Help - RateADrug
None noted currently. Side Effects: Chest pain or heavy feeling, discomfort spreading to the arm or shoulder, nausea, sweating, general ill feeling; Feeling short of breath, even with mild exertion; Sudden numbness or weakness, especially on one side of the body; Sudden headache, confusion, problems with vision, speech, or balance; or.
Rateadrug.comDailyMed - ARANESP- darbepoetin alfa injection, solution …
2019-01-30 · Initiate Aranesp treatment when the hemoglobin level is less than 10 g/dL. If the hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt the dose of Aranesp. The recommended starting dose is 0.45 mcg/kg intravenously or subcutaneously as a weekly injection or 0.75 mcg/kg once every 2 weeks as appropriate.
Dailymed.nlm.nih.govPRILOGA I POVZETEK GLAVNIH ZNAČILNOSTI ZDRAVILA - Europa
Aranesp 300 mikrogramov raztopina za injiciranje v viali Ena viala vsebuje 300 mikrogramov darbepoetina alfa v 1 ml (300 µg/ml). Darbepoetin alfa je pridobljen z gensko tehnologijo v ovarijskih celicah kitajskega hrčka (CHO-K1). Za celoten seznam pomožnih snovi glejte poglavje 6.1. 4 3. FARMACEVTSKA OBLIKA raztopina za injiciranje (injekcija) v napolnjeni injekcijski …
Ema.europa.eu
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| cerberuscollectables.com | godaddy.com | 66 Days |
| gaydia.com | above.com | -2 Years, -44 Days |
| taminnahade.com | onlinenic.com | -2 Years, -259 Days |
| kindermusik.com | godaddy.com | -2 Years, -282 Days |
| bt7partners.com | namecheap.com | -1 Years, -301 Days |
| phimxxx.asia | namecheap.com | -1 Years, -355 Days |
| prospectss.com | porkbun.com | -1 Years, -317 Days |
| gbrsf.com | networksolutions.com | 4 Years, 356 Days |
| omosuku.com | netowl.jp | -1 Years, -350 Days |
| tedpublications.com | namecheap.com | -2 Years, -104 Days |